Effect of COVID‐19 pandemic on treatment of Type 1 diabetes in children
Open Access
- 19 October 2020
- journal article
- editorial
- Published by Wiley in Acta Paediatrica
- Vol. 110 (3) , 933-934
Abstract
No abstract availableKeywords
This publication has 10 references indexed in Scilit:
- COVID-19 in people with diabetes: understanding the reasons for worse outcomesThe Lancet Diabetes & Endocrinology, 2020
- Managing New-Onset Type 1 Diabetes During the COVID-19 Pandemic: Challenges and OpportunitiesDiabetes Technology & Therapeutics, 2020
- Systematic review of COVID‐19 in children shows milder cases and a better prognosis than adultsActa Paediatrica, 2020
- HbA1c level as a risk factor for retinopathy and nephropathy in children and adults with type 1 diabetes: Swedish population based cohort studyBMJ, 2019
- Excess mortality and cardiovascular disease in young adults with type 1 diabetes in relation to age at onset: a nationwide, register-based cohort studyThe Lancet, 2018
- Exploring Variation in Glycemic Control Across and Within Eight High-Income Countries: A Cross-sectional Analysis of 64,666 Children and Adolescents With Type 1 DiabetesDiabetes Care, 2018
- Economic downturns, universal health coverage, and cancer mortality in high-income and middle-income countries, 1990–2010: a longitudinal analysisThe Lancet, 2016
- Impact of HbA1c, Followed From Onset of Type 1 Diabetes, on the Development of Severe Retinopathy and Nephropathy: The VISS Study (Vascular Diabetic Complications in Southeast Sweden)Diabetes Care, 2014
- HOW MANY INFANTS LIKELY DIED IN AFRICA AS A RESULT OF THE 2008–2009 GLOBAL FINANCIAL CRISIS?Health Economics, 2012
- The public health effect of economic crises and alternative policy responses in Europe: an empirical analysisThe Lancet, 2009